Lorlatinib latest price in 2024

Lorlatinib is a drug used to treat certain types of cancer and belongs to a class of drugs called tyrosine kinase inhibitors. It is primarily used to treat non-small cell lung cancer (NSCLC), particularly those who have developed mutations in the ALK (tyrosine kinase) or ROS1 genes.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

ALK and ROS1 gene mutations are common molecular alterations in some cancers, especially NSCLC. These mutations lead to abnormal tyrosine kinase activity, driving the growth and spread of cancer cells. Lorlatinib inhibits the growth of cancer cells by blocking these abnormal kinase activities, thereby playing a role in the treatment of cancers related to these genetic mutations.

Larlatinib has broader antitumor activity than some of the earlier ALK inhibitors and may be more effective in some patients who have progressed after prior treatment with other ALK inhibitors. In addition, lorlatinib is able to cross the blood-brain barrier and therefore can also be used to treat patients with brain metastases, which may be a limitation of some other drugs.

In clinical trials, lorlatinib has shown relatively good tolerability and safety, while achieving significant therapeutic effects. However, like all medications, it may cause some side effects, including but not limited to fatigue, nausea, vomiting, high blood pressure, etc.